Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

Similar documents
Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

FirstCarolinaCare Insurance Company. Step Therapy Requirements

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

Step Therapy Requirements. Effective: 11/01/2018

Step Therapy Requirements

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Step Therapy Requirements. Effective: 05/01/2018

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

ALLERGIC CONJUNCTIVITIS AGENTS

2017 Step Therapy Criteria

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

Step Therapy Requirements. Effective: 1/1/2019

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS

ALPHA BLOCKERS. Products Affected. Details. Step 2: RAPAFLO 4 MG CAPSULE. Step 1: alfuzosin extended release tablet doxazosin tablet

ANTIDIABETIC AGENTS - MISCELLANEOUS

**CRITERIA UNDER CMS REVIEW**

ACYCLOVIR OINT (CCHP2017)

ALZHEIMER'S DRUGS. Details. Step 2: Exelon Patch 13.3 mg/24 hour transdermal Exelon Patch 4.6 mg/24 hr transdermal

2018 Step Therapy Criteria

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

Step Therapy Criteria

2019 PDP Basic Step Therapy Document

ANTICONVULSANT STEP THERAPY

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

Step Therapy Group. Atypical Antipsychotic Agents

ACYCLOVIR OINT (CCHP2017)

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST)

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Drugs That Require Step Therapy (ST)

Drugs That Require Step Therapy (ST)

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)

ACYCLOVIR OINT (CCHP2017)

Step Therapy Medications

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

2019 Simply Step Therapy Document

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

Step Therapy Requirements. Effective: 03/01/2015

2018 Step Therapy FID 18088

ADHD STIMULANTS-S(SHC)

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

ADHD STIMULANTS - SCORE

ADHD STIMULANTS - SCORE

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

Avoid paying too much for your prescriptions

ANTICONVULSANT THERAPY

COLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS... 6

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES. SEDATIVE HYPNOTIC AGENTS Generic Brand HICL GCN Exception/Other ZOLPIDEM

COLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria

ALPHA BLOCKERS. Products Affected Step 1: Details. Step 2: Rapaflo 4 mg capsule Rapaflo 8 mg capsule

Step Therapy Requirements

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.

2018 WPS MedicareRx Plan (PDP) Step Therapy

Antipsychotic Medications Age and Step Therapy

ALPHA GLUCOSIDASE INHIBITOR THERAPY

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

Step Therapy Criteria

Cigna Drug and Biologic Coverage Policy

Transcription:

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO) Step Therapy Requirements Effective 4/1/2019 Updated 3/2019

BRAND NAME ANTIDEPRESSANTS FETZIMA 120 MG CAPSULE,EXTENDED RELEASE FETZIMA 20 MG (2)-40 MG (26) CAPSULE,EXTENDED RELEASE,24 HR,DOSE PACK FETZIMA 20 MG CAPSULE,EXTENDED RELEASE FETZIMA 40 MG CAPSULE,EXTENDED RELEASE FETZIMA 80 MG CAPSULE,EXTENDED RELEASE PAXIL 10 MG/5 ML ORAL SUSPENSION TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK VIIBRYD 10 MG TABLET VIIBRYD 20 MG TABLET VIIBRYD 40 MG TABLET USE OF A FIRST LINE GENERIC ANTIDEPRESSANT IN SSRI/SNRI CLASS OR GENERIC BUPROPION HYDROCHLORIDE 1

BRAND NAME ATYPICAL ANTIPSYCHOTICS FANAPT 1 MG TABLET FANAPT 10 MG TABLET FANAPT 12 MG TABLET FANAPT 1MG(2)-2 MG(2)-4MG(2)-6 MG(2) TABLETS IN A DOSE PACK FANAPT 2 MG TABLET FANAPT 4 MG TABLET FANAPT 6 MG TABLET FANAPT 8 MG TABLET LATUDA 120 MG TABLET LATUDA 20 MG TABLET LATUDA 40 MG TABLET LATUDA 60 MG TABLET LATUDA 80 MG TABLET REXULTI 0.25 MG TABLET REXULTI 0.5 MG TABLET REXULTI 1 MG TABLET REXULTI 2 MG TABLET REXULTI 3 MG TABLET REXULTI 4 MG TABLET SAPHRIS 10 MG SUBLINGUAL TABLET SAPHRIS 2.5 MG SUBLINGUAL TABLET SAPHRIS 5 MG SUBLINGUAL TABLET VRAYLAR 1.5 MG CAPSULE VRAYLAR 3 MG CAPSULE VRAYLAR 4.5 MG CAPSULE VRAYLAR 6 MG CAPSULE PRIOR HISTORY OR USE OF ONE FIRST LINE GENERIC ATYPICAL ANTIPSYCHOTIC AGENT 2

BRAND NAME SEDATIVE HYPNOTICS BELSOMRA 10 MG TABLET BELSOMRA 15 MG TABLET BELSOMRA 20 MG TABLET BELSOMRA 5 MG TABLET ROZEREM 8 MG TABLET ZOLPIMIST 5 MG/SPRAY (0.1 ML) ORAL SPRAY USE OF A FIRST LINE GENERIC SEDATIVE HYPNOTIC AGENT 3

JUXTAPID JUXTAPID 10 MG CAPSULE JUXTAPID 20 MG CAPSULE JUXTAPID 30 MG CAPSULE JUXTAPID 40 MG CAPSULE JUXTAPID 5 MG CAPSULE JUXTAPID 60 MG CAPSULE FIRST LINE USE OF REPATHA 4

LEVETIRACETAM SPRITAM 1,000 MG TABLET FOR ORAL SUSPENSION SPRITAM 250 MG TABLET FOR ORAL SUSPENSION SPRITAM 500 MG TABLET FOR ORAL SUSPENSION SPRITAM 750 MG TABLET FOR ORAL SUSPENSION USE OF FIRST-LINE GENERIC LEVETIRACETAM 5

OPHTHALMIC BETA BLOCKERS betaxolol 0.5 % eye drops timolol maleate 0.25 % eye gel forming solution timolol maleate 0.5 % eye gel forming solution FIRST-LINE USE OF GENERIC TIMOLOL MALEATE 0.25% OR 0.5% EYE DROPS 6

ULORIC ULORIC 40 MG TABLET ULORIC 80 MG TABLET FIRST LINE USE OF ALLOPURINOL 7

8

INDEX BELSOMRA 10 MG TABLET...3 BELSOMRA 15 MG TABLET...3 BELSOMRA 20 MG TABLET...3 BELSOMRA 5 MG TABLET... 3 betaxolol 0.5 % eye drops... 6 FANAPT 1 MG TABLET... 2 FANAPT 10 MG TABLET... 2 FANAPT 12 MG TABLET... 2 FANAPT 1MG(2)-2 MG(2)-4MG(2)-6 MG(2) TABLETS IN A DOSE PACK... 2 FANAPT 2 MG TABLET... 2 FANAPT 4 MG TABLET... 2 FANAPT 6 MG TABLET... 2 FANAPT 8 MG TABLET... 2 FETZIMA 120 MG CAPSULE,EXTENDED RELEASE... 1 FETZIMA 20 MG (2)-40 MG (26) CAPSULE,EXTENDED RELEASE,24 HR,DOSE PACK...1 FETZIMA 20 MG CAPSULE,EXTENDED RELEASE... 1 FETZIMA 40 MG CAPSULE,EXTENDED RELEASE... 1 FETZIMA 80 MG CAPSULE,EXTENDED RELEASE... 1 JUXTAPID 10 MG CAPSULE... 4 JUXTAPID 20 MG CAPSULE... 4 JUXTAPID 30 MG CAPSULE... 4 JUXTAPID 40 MG CAPSULE... 4 JUXTAPID 5 MG CAPSULE...4 JUXTAPID 60 MG CAPSULE... 4 LATUDA 120 MG TABLET...2 LATUDA 20 MG TABLET... 2 LATUDA 40 MG TABLET... 2 LATUDA 60 MG TABLET... 2 LATUDA 80 MG TABLET... 2 PAXIL 10 MG/5 ML ORAL SUSPENSION... 1 REXULTI 0.25 MG TABLET...2 REXULTI 0.5 MG TABLET...2 REXULTI 1 MG TABLET... 2 REXULTI 2 MG TABLET... 2 REXULTI 3 MG TABLET... 2 REXULTI 4 MG TABLET... 2 ROZEREM 8 MG TABLET... 3 SAPHRIS 10 MG SUBLINGUAL TABLET... 2 SAPHRIS 2.5 MG SUBLINGUAL TABLET... 2 SAPHRIS 5 MG SUBLINGUAL TABLET... 2 SPRITAM 1,000 MG TABLET FOR ORAL SUSPENSION... 5 SPRITAM 250 MG TABLET FOR ORAL SUSPENSION... 5 SPRITAM 500 MG TABLET FOR ORAL SUSPENSION... 5 SPRITAM 750 MG TABLET FOR ORAL SUSPENSION... 5 timolol maleate 0.25 % eye gel forming solution... 6 timolol maleate 0.5 % eye gel forming solution... 6 TRINTELLIX 10 MG TABLET... 1 TRINTELLIX 20 MG TABLET... 1 TRINTELLIX 5 MG TABLET... 1 ULORIC 40 MG TABLET...7 ULORIC 80 MG TABLET...7 VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK... 1 VIIBRYD 10 MG TABLET... 1 VIIBRYD 20 MG TABLET... 1 VIIBRYD 40 MG TABLET... 1 VRAYLAR 1.5 MG CAPSULE... 2 VRAYLAR 3 MG CAPSULE... 2 VRAYLAR 4.5 MG CAPSULE... 2 VRAYLAR 6 MG CAPSULE... 2 ZOLPIMIST 5 MG/SPRAY (0.1 ML) ORAL SPRAY...3 9